Trademark: SOLASTRA 1291245
Word
SOLASTRA
ID
1291245
Trademark Type
Word
Status
Cancelled: Cancelled at the request of IB
Application Date
20 February 2009
Registration Date
20 February 2009
Cancellation Date
10 October 2014
Owner(s)
Service
Refer to WIPO address for Correspondence
Goods and Services:
Class 1:
Reagents for scientific, bioresearch, biomedical, diagnostic and laboratory analysis; reagents for scientific and research use in the field of biotechnology; clinical and in vitro diagnostic reagents; antibody based reagents for scientific and research use, namely monoclonal antibodies; immunoassay test kits consisting primarily of in vitro reagents for the diagnosis and monitoring of conditions of physiological significance, all for laboratory, biotechnology, and bioresearch use
Reagents for scientific, bioresearch, biomedical, diagnostic and laboratory analysis; reagents for scientific and research use in the field of biotechnology; clinical and in vitro diagnostic reagents; antibody based reagents for scientific and research use, namely monoclonal antibodies; immunoassay test kits consisting primarily of in vitro reagents for the diagnosis and monitoring of conditions of physiological significance, all for laboratory, biotechnology, and bioresearch use
Class 5:
Reagents for medical purposes; diagnostic preparations for medical purposes; reagents for in vitro diagnosis as well as for clinical and medical laboratory use; medical diagnosis reagents; antibody-based reagents for medical use, namely, monoclonal antibodies, diagnostic assay test kits consisting of medical diagnostic reagents, and immunoassay test kits consisting primarily of in vitro reagents for the diagnosis and monitoring of physiological significance
Reagents for medical purposes; diagnostic preparations for medical purposes; reagents for in vitro diagnosis as well as for clinical and medical laboratory use; medical diagnosis reagents; antibody-based reagents for medical use, namely, monoclonal antibodies, diagnostic assay test kits consisting of medical diagnostic reagents, and immunoassay test kits consisting primarily of in vitro reagents for the diagnosis and monitoring of physiological significance